Dr. Daniel Geschwind is Co-Director of the UCLA CART and a Professor in the Departments of Neurology and Psychiatry at the UCLA School of Medicine. He is a member of the Center for Neurobehavioral Genetics in the UCLA Neuropsychiatric Institute and the UCLA Intercampus Medical Genetics training program. Dr. Geschwind also is Director of the UCLA Neurogenetics Program that includes a clinical and basic science component involving seven investigators. He chairs the scientific steering committee of the Autism Genetic Resource Exchange (AGRE), is a member of the Cure Autism Now (CAN) Scientific Advisory Board, and serves on the editorial board of Lancet, Neurology and Current Genomics. Widely published, Dr. Geschwind’s research involves the application of molecular genetic methods to studying brain-behavior relationships, with a focus on brain asymmetry and language. He has studied complex neurobehavioral phenotypes, including autism, frontotemporal dementia and Klinefelter’s syndrome, and he directs a collaborative multi-site autism genetics project involving investigators at Columbia, University of Chicago and UCLA. Dr. Geschwind received an M.D. in medicine and a Ph.D. in neurobiology from Yale University School of Medicine in 1991 prior to completing an internship in internal medicine, a residency in neurology and a postdoctoral fellowship in neurogenetics, all at the UCLA School of Medicine. He joined the UCLA faculty in 1997.